Ropivacaine
End Stage Renal Failure
The First People's Hospital of LianyungangSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the End Stage Renal Failure cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fluoxetine University of Arkansas | Phase 4 | BB |
Warfarin Nicholas Carlson | Phase 4 | BB |
Capsaicin Emma Aitken | Phase 4 | BB |
Lidocaine The First People's Hospital of Lianyungang | Phase 4 | BB |
Vitamin D University of Sao Paulo General Hospital | Phase 4 | BB |
View all 24 →
Same molecule, other indications
Ropivacaine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →